Results 71 to 80 of about 17,718 (201)

Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degeneration

Therapeutics and Clinical Risk Management, 2012
Youxin Chen, Fei HanDepartment of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaAbstract: Wet age-related macular degeneration (AMD) causes severe vision loss due
Chen Y, Han F
doaj  

Implementation studies of ranibizumab for neovascular age‐related macular degeneration [PDF]

, 2013
Sara Brandi Bloch
openalex   +1 more source

EFEKTIVITAS-BIAYA PENGGUNAAN BEVACIZUMAB DAN RANIBIZUMAB SEBAGAI ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PADA PASIEN DENGAN GANGGUAN MATA: TINJAUAN SISTEMATIS

Kartika: Jurnal Ilmiah Farmasi
Anti-vascular endothelial growth factor (VEGF) injeksi intravitreal dapat digunakan untuk terapi pasien dengan gangguan mata. Obat anti-VEGF yang digunakan di antaranya bevacizumab, ranibizumab, aflibercept, dan brolucizumab.
Nur Sidik Cahyono, Elin Yulinah Sukandar   +1 more
doaj   +1 more source

Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy

, 2020
Huijin Chen, Changguan Wang, Hongliang Dou, Xuefeng Feng, Yimin Xu, Zhizhong Ma   +5 more
openalex   +1 more source

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis

Clinical Ophthalmology, 2013
Masahiro Miura,1,2 Takuya Iwasaki,1,2 Hiroshi Goto2 1Department of Ophthalmology, Tokyo Medical University, Ibaraki Medical Center, Ami, Ibaraki, Japan; 2Department of Ophthalmology, Tokyo Medical University, Nishi-Shinjuku, Tokyo, Japan Purpose: To ...
Miura M, Iwasaki T, Goto H
doaj  

Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization [PDF]

, 2012
Timothy Y. Y. Lai, Franklin Luk, G K Y Lee, Dennis S.C. Lam   +3 more
openalex   +1 more source

VISUAL ACUITY OUTCOMES OF RANIBIZUMAB TREATMENT IN PATHOLOGIC MYOPIC EYES WITH MACULAR RETINOSCHISIS AND CHOROIDAL NEOVASCULARIZATION

, 2016
Lala Ćeklić, Marion R. Munk, Ute Wolf-Schnurrbusch, Margarita Gekkieva, Sebastián Wolf   +4 more
openalex   +1 more source

Multicenter Study of Infectious and Noninfectious Endophthalmitis after Intravitreal Ranibizumab Injections [PDF]

, 2014
Francisco J. Ascaso, Luís Arias, J.L. Olea, Laura Villén, Marta S. Figueroa, Eduardo Robles Esteban, Alfredo García‐Layana, P Rosenfeld, D Brown, J Heier, D Boyer, P Kaiser, D Brown, P Kaiser, M Michels, G Soubrane, J Heier, G Peyman, E Lad, D Moshfeghi, K Stepien, A Eaton, G Jaffe, J Davis, J Raja, P Rosenfeld, A Moshfeghi, C Puliafito, P Greenberg, A Martidis, A Rogers, J Duker, E Reichel, J Heier, A Antoszyk, P Pavan, S Leff, P Rosenfeld, K Klein, M Walsh, T Hassan, L Halperin, A Castellarin, A Fung, R Palanki, S Bakri, E Depperschmidt, A Gibson, J Gaudreault, D Fei, J Rusit, P Suboc, V Shiu, D Fintak, G Shah, K Blinder, C Regillo, J Pollack, R Jager, L Aiello, S Patel, E Cunningham, S Pilli, A Kotsolis, R Spaide, J Slakter, K Freund, J Mason, M White, R Feist, M Thomley, M Albert, D Chong, R Anand, P Williams, J Qureshi, D Callanan, D Brown, M Michels, P Kaiser, J Heier, J Sy, C Regillo, D Brown, P Abraham, H Yue, T Ianchulev, D Boyer, J Heier, D Brown, S Francom, T Ianchulev, A Bhavsar, J Googe, Jr, C Stockdale, N Bressler, A Brucker, L Lima, S Zweifel   +99 more
openalex   +1 more source

Aflibercept in refractory wet AMD treated with ranibizumab: Anatomical and visual outcome

, 2016
Sleiman Abou-Ltaif
openalex   +1 more source

Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial [PDF]

, 2010
Manju L. Subramanian, Gelareh Abedi, Steven Ness, E Ahmed, M. J. Fenberg, Margaret Daly, Antoun Houranieh, Edward Feinberg   +7 more
openalex   +1 more source